← Back to Search

Non-invasive Brain Stimulation

Linear Asymmetric rTMS System for Major Depressive Disorder

N/A
Waitlist Available
Led By Kathleen Pajer, MD
Research Sponsored by NeuroQore Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 10 months
Awards & highlights

Study Summary

This trial is investigating a new, more tolerable rTMS treatment for adolescents with treatment-resistant depression.

Eligible Conditions
  • Major Depressive Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 10 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Completion Rate
Patient Enrollment Rate
Patient Experience
+1 more
Secondary outcome measures
Change in clinician-rated MDD symptoms
Change in function
Change in mental status
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: AdolescentsExperimental Treatment1 Intervention
Device: First Dawn rTMS System used in 18 patients divided into groups of 3. Each group will receive a different and gradually increasing frequency of treatment sessions/day (1-10) over a decreasing number of days (10-1). The total number of pulses for all levels will be 30,000. The use of each level will be dependent on tolerability and safety of the previous lower level, i.e., if one level is not tolerated well by a group, progression to the next level will not occur.

Find a Location

Who is running the clinical trial?

NeuroQore Inc.Lead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
Children's Hospital of Eastern OntarioOTHER
126 Previous Clinical Trials
55,463 Total Patients Enrolled
Kathleen Pajer, MDPrincipal InvestigatorChildren's Hospital of Eastern Ontario (CHEO)
1 Previous Clinical Trials
152 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day
2022. "Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03986658.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top